2023 ESC Guidelines for the management of cardiomyopathies
Рекомендации Европейского общества кардиологов (ESC) 2023 года по ведению пациентов с кардиомиопатиями
2023-08-25
SCID: 54.1/wjn5zghs
Discuss with AI
ESC Guidelinescardiomyopathiesdiagnostic approachesrisk-benefit assessmenttherapeutic approaches
Figures from the paper
Abstract (AI)
2 Representing the European Society of Human Genetics (ESHG) ESC Clinical Practice Guidelines (CPG) Committee: listed in the Appendix.
Key Findings
1
Guideline recommendations were developed using predefined ESC scales and voting procedures, with every approved recommendation achieving at least 75% agreement.
2
The 2023 ESC Guidelines evaluate available evidence to support individualized diagnostic and therapeutic decisions for patients with cardiomyopathies.
3
The Task Force composition sought broad representation across the ESC region and relevant subspecialties, with consideration of gender and country diversity.
4
The Task Force critically assessed diagnostic and therapeutic approaches, including their risk–benefit ratios, and graded recommendations by strength and evidence level.
5
The guidelines represent the official ESC position on cardiomyopathy management and are intended for use alongside clinician judgment, patient circumstances, and applicable national regulations.
Research Object
Management guidelines for cardiomyopathies (2023 ESC Guidelines)
Research Subject
diagnostic and therapeutic management, including risk–benefit assessment, of patients with cardiomyopathies
Publication Details
Publication Date
2023-08-25
Journal
Publisher
ISSN
Cited by
2770
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai3
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure2021
Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging2015
2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death2022
Cited by3
2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)2024
Efficacy of pharmacological therapies in reducing outflow tract obstruction in patients with obstructive hypertrophic cardiomyopathy: a systematic review and meta-analysis2025
Thick filament molecular interfaces play a critical role in the pathogenesis of hypertrophic cardiomyopathy2026